Morales-Orue, IgnacioZafra-Martin, JuanGarcia, LauraChicas-Sett, RodolfoCastilla-Martinez, JuanAuxiliadora Cabezon, MariaBurgos, JavierLloret, MartaLara, Pedro C.2025-01-072025-01-072020-01-012218-676Xhttps://hdl.handle.net/10668/25001Breast cancer (BC) is the principal cause of cancer-related death in women. Metastatic patients are usually treated with a systemic therapy, but clinical results are limited. Oligometastatic subjects can benefit from high-precision radiotherapy techniques to potentially achieve a complete response. Currently, there is limited evidence of stereotactic ablative radiotherapy (SABR) treatments in elderly oligometastatic cancer patients. A review of the medical literature was performed in PubMed database to assess the current role of SABR in the treatment of breast oligometastases in elderly patients. SABR represents a feasible and safe therapeutic approach in oligometastatic elderly BC patients. Further studies are required to establish the optimum patient selection and treatment scheme.enAttribution-NonCommercial-NoDerivatives 4.0 Internationalhttp://creativecommons.org/licenses/by-nc-nd/4.0/Stereotactic ablative radiotherapy (SABR)elderlyoligometastaticradiotherapybreastBody radiation-therapyQuality-of-lifeBrain metastasesCombination chemotherapyInternational societyGeriatric assessmentFollow-upRadiosurgeryOncologySbrtreview35117963open access10.21037/tcr.2019.08.292219-6803https://doi.org/10.21037/tcr.2019.08.29507394100024